Assessment of Functional Visual Acuity in Patients with Blepharospasm - Functional Visual Acuity in Blepharospasm

Miyata Eye Hospital0 sites40 target enrollmentJuly 6, 2020

Overview

No summary available.

Registry

who.int

Start Date

July 6, 2020

End Date

June 30, 2025

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

•1\) Symptomatic eyelid spasm Patients with a history of Parkinson's disease, progressive supranuclear palsy, etc. 2\) History of botulinum toxin treatment within 6 months prior to survey. 3\) Patients with systemic neuromuscular junction disorders. Myasthenia gravis, Lambert\-Eaton syndrome, amyotrophic lateral sclerosis, etc. 4\) Patients with cerebrovascular disease with paralysis 5\) Patients with facial nerve palsy 6\) Patients with glaucoma or ocular hypertension under treatment 7\) Patients with active uveitis 8\) Patients with corneal and conjunctival diseases, excluding dry eyes 9\) Patients with macular diseases (e.g. age\-related macular degeneration, epiretinal membrane, etc.) 10\) Patients with retinal diseases (e.g., retinal vascular disorder, retinitis pigmentosa, myopic changes, etc.) 11\)Patients with intense myopia greater than \-6D 12\) Other patients who are deemed inappropriate by the physician, such as those with systemic or ophthalmic diseases